Stay updated on EPIK-B2 Study: Alpelisib with Trastuzumab & Pertuzumab Clinical Trial

Sign up to get notified when there's something new on the EPIK-B2 Study: Alpelisib with Trastuzumab & Pertuzumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the EPIK-B2 Study: Alpelisib with Trastuzumab & Pertuzumab Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    An NIH-wide banner announces transition updates and says federal agencies are using “Super Intelligence” (SI) in place of “Artificial Intelligence” (AI). The study page itself still displays a 403 error.
    Difference
    1%
    Check dated 2026-10-26T15:48:26.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The revision identifier in the footer changes from v3.7.1 to v3.7.2; the study record remains inaccessible.
    Difference
    0.2%
    Check dated 2026-10-19T15:48:37.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-12T15:45:46.000Z thumbnail image
  4. Check
    36 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, replacing the study record content with a generic error page, which blocks access to the study details.
    Difference
    20%
    Check dated 2026-09-21T22:37:36.000Z thumbnail image
  5. Check
    58 days ago
    Change Detected
    Summary
    The page’s revision stamp changed from v3.6.5 to v3.6.6, signaling a minor update to the site. No substantive study details or content appear to be changed.
    Difference
    0.1%
    Check dated 2026-08-31T17:42:14.000Z thumbnail image
  6. Check
    79 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.5, replacing the previous Revision: v3.6.4. This indicates a minor release update to the page's version metadata rather than a content change.
    Difference
    0.0%
    Check dated 2026-08-10T15:25:30.000Z thumbnail image

Stay in the know with updates to EPIK-B2 Study: Alpelisib with Trastuzumab & Pertuzumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the EPIK-B2 Study: Alpelisib with Trastuzumab & Pertuzumab Clinical Trial page.